Table 1.
| |||||||
---|---|---|---|---|---|---|---|
Animal ID |
Duration of infection (days post infection) |
Route of Infection |
Viral load- Plasma Copies/mL (106) |
Viral load- Colon Copies/mg RNA (106) |
Histopathology (colon) |
Histopathology (Jejunum) |
Colon Histo- pathology score |
| |||||||
Chronic SIV-Infected | |||||||
| |||||||
FE53* | 140 | I/rectal | 0.3 | 5 | Mild colitis | ND | 1 |
FT11* | 145 | I/v | 500 | 2075 | Moderate colitis | Mild enteritis | 2 |
GH25* | 148 | I/v | NA | 300 | Mild suppurative colitis | Mild enteritis | 1 |
CP47* | 151 | I/v | NA | 0.9 | Mild colitis | ND | 1 |
HI68* | 158 | I/vag | 8 | 3 | Mild colitis | ND | 1 |
HB31* | 180 | I/v | 3000 | 200 | Lymphoid hyperplasia | Lymphoid hyperplasia | 1 |
HB48* | 180 | I/v | 20 | 0.8 | ND | Mild enteritis | 0 |
GK31* | 180 | I/v | 30 | 3 | ND | ND | 0 |
GA19* | 180 | I/v | 100 | 600 | Lymphoid hyperplasia | ND | 1 |
DV42* | 226 | I/vag | 0.1 | 1 | Mild colitis | ND | 1 |
HG45* | 281 | I/vag | 0.9 | 0.3 | ND | ND | 0 |
HG58* | 286 | I/vag | 0.007 | 0.2 | ND | ND | 0 |
| |||||||
HD08 | 90 | I/v | NA | 300 | Moderate colitis/cryptitis | Moderate enteritis | 2 |
DE50 | 129 | I/vag | NA | 0.3 | Mild colitis | ND | 1 |
HN15 | 177 | I/vag | NA | 0.3 | Granulomatous colitis | Granulomatous enteritis | 3 |
HL01 | 180 | I/vag | 7 | 0.8 | ND | Mild Amyloidosis | 0 |
HF27 | 180 | I/v | 40 | 0.04 | Lymphoid hyperplasia | Lymphoid hyperplasia | 1 |
HV95 | 180 | I/v | 10 | 0.1 | Moderate Colitis | ND | 2 |
FE24 | 271 | I/v | 3.1 | 0.3 | Mild colitis | ND | 1 |
EI15 | 300 | I/v | 0.4 | 0.9 | Mild colitis | Mild enteritis | 1 |
R191 | 786 | I/v | NA | NA | Severe colitis | ND | 3 |
| |||||||
Uninfected Controls | |||||||
| |||||||
EL66* | NA | NA | NA | NA | NA | NA | 0 |
EH70* | NA | NA | NA | NA | NA | NA | 0 |
EH80* | NA | NA | NA | NA | NA | NA | 0 |
FK25* | NA | NA | NA | NA | NA | NA | 0 |
| |||||||
GT20 | NA | NA | NA | NA | NA | NA | 0 |
IC52 | NA | NA | NA | NA | NA | NA | 0 |
HT74 | NA | NA | NA | NA | NA | NA | 0 |
IH95 | NA | NA | NA | NA | NA | NA | 0 |
IT62 | NA | NA | NA | NA | NA | NA | 0 |
IT13 | NA | NA | NA | NA | NA | NA | 0 |
EJ34 | NA | NA | NA | NA | NA | NA | 0 |
HF54-Pre | NA | NA | NA | NA | NA | NA | 0 |
HR42-Pre | NA | NA | NA | NA | NA | NA | 0 |
HD08-Pre | NA | NA | NA | NA | NA | NA | 0 |
HE68 | NA | NA | NA | NA | NA | NA | 0 |
HP84 | NA | NA | NA | NA | NA | NA | 0 |
|
Colon tissue from 12 chronic SIV-infected (FE53-HG58) and 4 uninfected control (EL66-FK25) macaques shown above the dotted line was used for TLDA miRNA profiling. Colon tissues from all SIV-infected (with exception of CP47, HG58 and R191) and 9 uninfected (GT20-HR42) were used for miRNA qRT-PCR confirmation studies Colon tissues from R191 and three uninfected controls (HD08-Pre, HE68 and HP84) were used for immunofluorescence studies. I/v- Intravenous, I/vag- Intravaginal, I/rectal- Intrarectal , NA- Not applicable for Uninfected controls and Not available for Chronic SIV-infected macaques, ND- None detected